Clear Filters Michael J. Fox Foundation: 2024 Parkinson’s Disease Therapeutics Conference October 21, 2024 Michael J. Fox Foundation: 2024 Parkinson’s Disease Therapeutics Conference Read More Human clinical trials: Single ascending dose (SAD) and Multiple ascending dose (MAD) studies October 2, 2024 Human clinical trials: Single ascending dose (SAD) and Multiple ascending dose (MAD) studies Read More H.C WainwrightGlobal Investment Conference and and International Congress of Parkinson’s Disease and Movement Disorders September 24, 2024 H.C WainwrightGlobal Investment Conference and and International Congress of Parkinson’s Disease and Movement Disorders Read More Ryan Reynolds Opens Up About His Father’s Early Parkinson’s Symptoms: The Subtle Signs His Family Missed September 24, 2024 Ryan Reynolds Opens Up About His Father’s Early Parkinson’s Symptoms: The Subtle Signs His Family Missed Read More Biomarkers and their involvement in neurodegenerative diseases September 24, 2024 Biomarkers and their involvement in neurodegenerative diseases Read More Gain Therapeutics speaks with Ram Selvaraju at H.C. Wainwright’s Annual Neuro Perspectives Virtual Conference September 24, 2024 Gain Therapeutics speaks with Ram Selvaraju at H.C. Wainwright’s Annual Neuro Perspectives Virtual Conference Read More GT-02287: A Promising GCase Enhancer in the Fight Against GBA1-Parkinson’s Disease September 24, 2024 GT-02287: A Promising GCase Enhancer in the Fight Against GBA1-Parkinson’s Disease Read More The role of the immune system in neurodegenerative diseases September 24, 2024 The role of the immune system in neurodegenerative diseases Read More Discovery of allosteric regulators with clinical potential to stabilize alpha-L-iduronidase in mucopolysaccharidosis type I September 24, 2024 Discovery of allosteric regulators with clinical potential to stabilize alpha-L-iduronidase in mucopolysaccharidosis type I Read More Corporate Presentation August 2024 Corporate Presentation Download